Key Points
GMO Product Platform stock rises 1.8% to ¥1,711 on JPX today.
Revenue growth of 35.7% and ROE of 17.6% support premium valuation.
Meyka AI forecasts ¥2,548 target, implying 49% upside potential.
B+ grade and buy rating reflect strong fundamentals in AI survey services.
GMO Product Platform, Inc. (3695.T) gained 1.8% on the JPX today, closing at ¥1,711 as the Tokyo-based company continues expanding its AI-powered audience engagement platform. The Industrials sector specialist, formerly known as GMO Research, Inc., provides quick survey services and automated data collection solutions across Asia. With a market cap of ¥7.53 billion, 3695.T trades above its 50-day average of ¥1,687 but remains below its 200-day average of ¥1,992. The stock’s intraday momentum reflects growing investor interest in the company’s digital transformation strategy.
3695.T Stock Performance and Technical Setup
GMO Product Platform shares opened at ¥1,685 and reached a day high of ¥1,711, gaining ¥31 from the previous close of ¥1,680. Volume traded 1,600 shares, below the 30-day average of 3,087, suggesting modest liquidity. The stock trades above its 50-day moving average but remains 13.8% below its 52-week high of ¥1,975.
Technical indicators show mixed signals. The RSI sits at 52.3, indicating neutral momentum, while the MACD histogram of 2.60 suggests early bullish divergence. The ADX reading of 26.97 confirms a strong trend is forming. Bollinger Bands place the stock near the middle band at ¥1,690, with upper resistance at ¥1,781 and lower support at ¥1,598.
Financial Metrics and Valuation
3695.T trades at a P/E ratio of 40.9 with earnings per share of ¥41.83, reflecting premium valuation relative to the Industrials sector average of 16.85. The price-to-sales ratio of 1.00 aligns with sector norms, while the price-to-book ratio of 3.15 suggests investors value the company’s growth prospects. Revenue per share stands at ¥1,703, with net income per share at ¥94.19.
The company maintains a strong balance sheet with cash per share of ¥1,262 and a debt-to-equity ratio of 0.26, well below the sector average of 0.38. Return on equity of 17.6% outpaces the Industrials sector average of 10.15%, demonstrating efficient capital deployment. Meyka AI rates 3695.T with a grade of B+, suggesting a buy recommendation based on strong fundamentals and sector comparison.
Growth Drivers and Market Position
GMO Product Platform reported revenue growth of 35.7% year-over-year, with gross profit climbing 50.3% and operating income rising 44.9%. These metrics reflect strong demand for the company’s Asia Cloud Panel and custom survey services. The company operates in the Specialty Business Services industry within Industrials, competing against larger conglomerates but maintaining a niche focus.
The company pays a dividend of ¥59.52 per share, yielding 3.48% annually. With 4.4 million shares outstanding, the market cap of ¥7.53 billion positions 3695.T as a mid-cap player. Track 3695.T on Meyka for real-time updates on this AI-focused survey platform specialist.
Price Forecast and Analyst Outlook
Meyka AI’s forecast model projects 3695.T reaching ¥2,548 within 12 months, implying 49% upside from current levels. The three-year forecast of ¥2,451 and five-year forecast of ¥2,366 suggest sustained appreciation potential. These projections factor in revenue growth momentum and sector tailwinds in digital research services.
The company’s earnings announcement is scheduled for July 30, 2026, which could provide fresh catalysts. Analysts rate the stock as a buy based on strong ROE performance and DCF valuation scores of 5 out of 5. However, the elevated P/E ratio warrants caution for value-focused investors seeking entry points.
Final Thoughts
GMO Product Platform’s 1.8% gain reflects solid fundamentals and growth momentum in AI-powered survey services. The company’s 35.7% revenue growth, strong ROE of 17.6%, and B+ Meyka grade support the bullish technical setup. With a 12-month price target of ¥2,548, the stock offers meaningful upside for investors comfortable with the elevated valuation. Earnings in July will be critical to validate growth projections and justify the premium multiple.
FAQs
GMO Product Platform gained on investor interest in its AI-powered audience engagement platform and strong 35.7% year-over-year revenue growth, supporting its digital transformation narrative.
Meyka AI rates 3695.T with a B+ grade and buy recommendation, factoring in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI projects 3695.T reaching ¥2,548 within 12 months, implying 49% upside from the current price of ¥1,711.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)